CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD
Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory condition. Given patients with COPD continue to experience exacerbations despite the availability of effective therapies, anti-inflammatory treatments targeting novel pathways are needed. Kinases, notably the phosphoinositide 3-k...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
19 October 2024
|
| In: |
Respiratory research
Year: 2024, Jahrgang: 25, Pages: 1-13 |
| ISSN: | 1465-993X |
| DOI: | 10.1186/s12931-024-02999-5 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12931-024-02999-5 Verlag, kostenfrei, Volltext: https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-024-02999-5 
|
| Verfasserangaben: | Mirco Govoni, Michele Bassi, Luca Girardello, Germano Lucci, François Rony, Rémi Charretier, Dmitry Galkin, Maria Laura Faietti, Barbara Pioselli, Gloria Modafferi, Rui Benfeitas, Martina Bonatti, Daniela Miglietta, Jonathan Clark, Frauke Pedersen, Anne-Marie Kirsten, Kai-Michael Beeh, Oliver Kornmann, Stephanie Korn, Andrea Ludwig-Sengpiel and Henrik Watz |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1923468723 | ||
| 003 | DE-627 | ||
| 005 | 20250717011128.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250423s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12931-024-02999-5 |2 doi | |
| 035 | |a (DE-627)1923468723 | ||
| 035 | |a (DE-599)KXP1923468723 | ||
| 035 | |a (OCoLC)1528044709 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Govoni, Mirco |e VerfasserIn |0 (DE-588)1363794299 |0 (DE-627)1923469959 |4 aut | |
| 245 | 1 | 0 | |a CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD |c Mirco Govoni, Michele Bassi, Luca Girardello, Germano Lucci, François Rony, Rémi Charretier, Dmitry Galkin, Maria Laura Faietti, Barbara Pioselli, Gloria Modafferi, Rui Benfeitas, Martina Bonatti, Daniela Miglietta, Jonathan Clark, Frauke Pedersen, Anne-Marie Kirsten, Kai-Michael Beeh, Oliver Kornmann, Stephanie Korn, Andrea Ludwig-Sengpiel and Henrik Watz |
| 264 | 1 | |c 19 October 2024 | |
| 300 | |b Illustrationen | ||
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.04.2025 | ||
| 520 | |a Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory condition. Given patients with COPD continue to experience exacerbations despite the availability of effective therapies, anti-inflammatory treatments targeting novel pathways are needed. Kinases, notably the phosphoinositide 3-kinases (PI3K), are thought to be involved in chronic airway inflammation, with this pathway proposed as a critical regulator of inflammation and oxidative stress response in COPD. CHF6523 is an inhaled PI3Kδ inhibitor that has shown positive preclinical results. This manuscript reports the results of a study of CHF6523 in patients with stable COPD (chronic bronchitis phenotype), and who had evidence of type-2 inflammation. | ||
| 650 | 4 | |a Gene expression profiling | |
| 650 | 4 | |a Multi-omics | |
| 650 | 4 | |a Phosphatidylinositol 3-kinases | |
| 650 | 4 | |a Proteomics | |
| 650 | 4 | |a Therapeutics | |
| 700 | 1 | |a Bassi, Michele |e VerfasserIn |4 aut | |
| 700 | 1 | |a Girardello, Luca |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lucci, Germano |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rony, François |e VerfasserIn |4 aut | |
| 700 | 1 | |a Charretier, Rémi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Galkin, Dmitry |e VerfasserIn |4 aut | |
| 700 | 1 | |a Faietti, Maria Laura |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pioselli, Barbara |e VerfasserIn |4 aut | |
| 700 | 1 | |a Modafferi, Gloria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Benfeitas, Rui |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bonatti, Martina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Miglietta, Daniela |e VerfasserIn |4 aut | |
| 700 | 1 | |a Clark, Jonathan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pedersen, Frauke |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kirsten, Anne-Marie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Beeh, Kai-Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kornmann, Oliver |e VerfasserIn |4 aut | |
| 700 | 1 | |a Korn, Stephanie |d 1980- |e VerfasserIn |0 (DE-588)131754483 |0 (DE-627)513603298 |0 (DE-576)298718855 |4 aut | |
| 700 | 1 | |a Ludwig-Sengpiel, Andrea |e VerfasserIn |4 aut | |
| 700 | 1 | |a Watz, Henrik |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Respiratory research |d London : BioMed Central, 2001 |g 25(2024), Artikel-ID 380, Seite 1-13 |h Online-Ressource |w (DE-627)326646485 |w (DE-600)2041675-1 |w (DE-576)107014823 |x 1465-993X |7 nnas |a CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD |
| 773 | 1 | 8 | |g volume:25 |g year:2024 |g elocationid:380 |g pages:1-13 |g extent:13 |a CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12931-024-02999-5 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-024-02999-5 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250423 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 131754483 |a Korn, Stephanie |m 131754483:Korn, Stephanie |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PK131754483 |e 950000PK131754483 |e 950900PK131754483 |e 50000PK131754483 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 19 | ||
| 999 | |a KXP-PPN1923468723 |e 4708765355 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"pubHistory":["1.2000 -"],"disp":"CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPDRespiratory research","part":{"pages":"1-13","volume":"25","year":"2024","extent":"13","text":"25(2024), Artikel-ID 380, Seite 1-13"},"recId":"326646485","type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"Respiratory research","title_sort":"Respiratory research"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 04.08.22"],"id":{"issn":["1465-993X"],"eki":["326646485"],"zdb":["2041675-1"]},"origin":[{"publisherPlace":"London","dateIssuedKey":"2001","dateIssuedDisp":"2001-","publisher":"BioMed Central"}]}],"person":[{"role":"aut","family":"Govoni","display":"Govoni, Mirco","given":"Mirco"},{"given":"Michele","display":"Bassi, Michele","family":"Bassi","role":"aut"},{"given":"Luca","role":"aut","display":"Girardello, Luca","family":"Girardello"},{"given":"Germano","role":"aut","display":"Lucci, Germano","family":"Lucci"},{"given":"François","role":"aut","family":"Rony","display":"Rony, François"},{"given":"Rémi","family":"Charretier","display":"Charretier, Rémi","role":"aut"},{"given":"Dmitry","family":"Galkin","display":"Galkin, Dmitry","role":"aut"},{"given":"Maria Laura","display":"Faietti, Maria Laura","family":"Faietti","role":"aut"},{"role":"aut","display":"Pioselli, Barbara","family":"Pioselli","given":"Barbara"},{"role":"aut","family":"Modafferi","display":"Modafferi, Gloria","given":"Gloria"},{"role":"aut","family":"Benfeitas","display":"Benfeitas, Rui","given":"Rui"},{"role":"aut","family":"Bonatti","display":"Bonatti, Martina","given":"Martina"},{"given":"Daniela","role":"aut","display":"Miglietta, Daniela","family":"Miglietta"},{"given":"Jonathan","role":"aut","family":"Clark","display":"Clark, Jonathan"},{"given":"Frauke","role":"aut","family":"Pedersen","display":"Pedersen, Frauke"},{"given":"Anne-Marie","family":"Kirsten","display":"Kirsten, Anne-Marie","role":"aut"},{"given":"Kai-Michael","display":"Beeh, Kai-Michael","family":"Beeh","role":"aut"},{"family":"Kornmann","display":"Kornmann, Oliver","role":"aut","given":"Oliver"},{"given":"Stephanie","role":"aut","display":"Korn, Stephanie","family":"Korn"},{"given":"Andrea","family":"Ludwig-Sengpiel","display":"Ludwig-Sengpiel, Andrea","role":"aut"},{"role":"aut","display":"Watz, Henrik","family":"Watz","given":"Henrik"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"19 October 2024"}],"recId":"1923468723","id":{"eki":["1923468723"],"doi":["10.1186/s12931-024-02999-5"]},"note":["Gesehen am 23.04.2025"],"name":{"displayForm":["Mirco Govoni, Michele Bassi, Luca Girardello, Germano Lucci, François Rony, Rémi Charretier, Dmitry Galkin, Maria Laura Faietti, Barbara Pioselli, Gloria Modafferi, Rui Benfeitas, Martina Bonatti, Daniela Miglietta, Jonathan Clark, Frauke Pedersen, Anne-Marie Kirsten, Kai-Michael Beeh, Oliver Kornmann, Stephanie Korn, Andrea Ludwig-Sengpiel and Henrik Watz"]},"title":[{"title":"CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD","title_sort":"CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD"}],"physDesc":[{"noteIll":"Illustrationen","extent":"13 S."}],"language":["eng"]} | ||
| SRT | |a GOVONIMIRCCHF6523DAT1920 | ||